{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/50242-554#drug","name":"Ocrevus Zunovo","alternateName":"ocrelizumab and hyaluronidase","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"50242-554"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761371"},{"@type":"PropertyValue","propertyID":"UNII","value":"743QUY4VD8|A10SJL62JY"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"b216af61-99d0-42a3-afc2-b5bf86df1ec0"}],"activeIngredient":"HYALURONIDASE (HUMAN RECOMBINANT), OCRELIZUMAB","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Genentech, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761371","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b216af61-99d0-42a3-afc2-b5bf86df1ec0","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-554"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T05:56:38.291Z"}}